Skip to main content
SpringerLink
Log in

Marfan Syndrome and Related Disorders of Fibrillin

  • Chapter
Molecular Genetics of Cardiac Electrophysiology

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 231))

  • 112 Accesses

Abstract

Marfan syndrome is a heritable disorder of connective tissue affecting approximately one in every 5 – 10,000 individuals. If all related disorders of fibrillin are included, the incidence of fibrillin abnormalities may be as high as one in every 3 – 5,000 (1). The cardinal clinical manifestations of the syndrome involve the skeletal, cardiovascular, and ocular systems (2,3). A characteristic body habitus, aneurysmal dilatation of the aorta (Figure 1), and ectopia lentis (subluxation or dislocation of the ocular lens) are the hallmarks of this condition. In addition, the skin, fascia, central nervous system, and lung may show characteristic involvement. Marfan syndrome is inherited in an autosomal dominant fashion, although an estimated 15 to 30 percent of cases are sporadic, representing new mutations in otherwise unaffected families. Males and females are equally affected, and there is no preference for race or ethnic group.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Pyeritz RE. 1996. Marfan syndrome and other disorders offîbrillin. In Principles and practice of medical genetics, 3rd ed. DL Rimoin, JM Connors, RE Pyeritz, editors. Churchill Livingstone, New York. 1027–1066.

    Google Scholar 

  2. Pyeritz RE. 1986. The diagnosis and management of the Marfan syndrome. AmFam Physician 34:83–94.

    CAS  Google Scholar 

  3. Pyeritz RE, VA McKusick. 1979. The Marfan syndrome diagnosis and management. N Engl J Med 300:772–777.

    Article  PubMed  CAS  Google Scholar 

  4. Goodman RM, M Berkenstadt, M Motro, M Frank. 1989. The Marfan syndrome in Israel (abstract). Am J Med Genet 32:242.

    Google Scholar 

  5. Gordon AM. 1962. Abraham Lincoln—A medical appraisal. J KentuckyMed Assoc 60:249–253.

    CAS  Google Scholar 

  6. McKusick VA. 1991. The defect in Marfan syndrome. Nature 325:279–281.

    Article  Google Scholar 

  7. Schoenfeld MR. 1978. Nicolo Paganini: Musical magician and Marfan mutant? JAMA 239:40–2.

    Article  PubMed  CAS  Google Scholar 

  8. Baer RW, HB Taussig, EH Oppenheimer. 1943. Congenital aneurysmal dilatation of the aorta associated with arachnodactyly. Bull Johns HopkinsHosp 72:309–331.

    Google Scholar 

  9. Etter LE, LP Glover. 1943. Arachnodactyly complicated by dislocated lens and death from rupture of dissecting aneurysm of the aorta. JAMA 123:88–89.

    Article  Google Scholar 

  10. Brown OR, H DeMots, FE Kloster, A Roberts, VD Menashe, RK Beals. 1975. Aortic root dilatation and mitral valve prolapse in Marfan’s syndrome: Circulation 52:651–657.

    Article  PubMed  CAS  Google Scholar 

  11. Murdoch JL, BA Walker, BL Halpern, JW Kuzma, VA McKusick. Life expectancy and causes of death in Marfan syndrome. 1972. N Engl J Med 286:804–808.

    Article  PubMed  CAS  Google Scholar 

  12. Shores J, KR Berger, EA Murphy, RE Pyeritz. 1994. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan’s syndrome.N Engl J Med 330:1335–41.

    Article  PubMed  CAS  Google Scholar 

  13. Silverman DI, KJ Burton, J Gray, MS Bosner, NT Kouchoukos, MJ Roman, M Boxer, RB Devereux, P Tsipouras. 1995. Life expectancy in the Marfan syndrome. Am J Cardiol 75:157–60.

    Article  PubMed  CAS  Google Scholar 

  14. Gott, VL, DE Cameron, RE Pyeritz, AM Gillinov, PS Greene, CD Stone, De Alejo, VA McKusick, 1994. Composite graft repair of Marfan aneurysm of the ascending aorta. J Card Surg 9:482–489

    Article  PubMed  CAS  Google Scholar 

  15. Finkbohner RD Johnston, SO Crawford, J Coselli, and D. M. Milewicz. 1995. Marfan syndrome. Long-term survival and complications after aortic aneurysm repair. Circulation 91:728–733.

    Article  PubMed  CAS  Google Scholar 

  16. Pyeritz RE. 1989. Pleiotropy revisited: Molecular explanations of a classic concept. Am J Med Genet 34:124–134.

    Article  PubMed  CAS  Google Scholar 

  17. Dietz HC, RE Pyeritz. 1995. Mutations in the human gene for fibrillin-1 (FBN 1) in the Marfan syndrome and related disorders. HumMolec Genet 4:1799–1809.

    CAS  Google Scholar 

  18. Ramirez F. 1996. Fibrillin mutations in Marfan syndrome and related phenotypes. Curr Opin Genet Dev 6:309–315.

    Article  PubMed  CAS  Google Scholar 

  19. Sakai LY, DR Keene, E Engvall. 1986. Fibrillin, a new 350 kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol 103:2499–2509.

    Article  PubMed  CAS  Google Scholar 

  20. Lee B, M Godfrey, E Vitale, H Hori, MG Mattei, M Sarfarazi, P Tsipouras, F Ramirez, DW Hollister. 1991. Linkage of Marfan syndrome and a phenotypically related disorderto two different fibrillin genes. Nature 352:330–334.

    Article  PubMed  CAS  Google Scholar 

  21. Maslen CL, GM Corson, BK Maddox, RW Glanville, LY Sakai. 1991. Partial sequence of a candidate gene for the Marfan syndrome. Nature 352:334–337.

    Article  PubMed  CAS  Google Scholar 

  22. Dietz HC, GR Cutting, RE Pyeritz, CL Maslen, LY Sakai, GM Corson, EG Puffenberger, A Hamosh, SM Curristin, G Stetten, DA Meyers, CA Francomano. 1991. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352:337–9.

    Article  PubMed  CAS  Google Scholar 

  23. Dietz HC, I Mclntosh, LY Sakai, GM Corson, SC Chalberg, RE Pyeritz, CA Francomano. 1993. Four novel FBN 1 mutations: Significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome. Genomics 17:468–475.

    Article  PubMed  CAS  Google Scholar 

  24. Nijbroek G, S Sood, I Mclntosh, CA Francomano, E Bull, L Pereira, F Ramirez, RE Pyeritz, HC Dietz. 1995. Fifteen novel FBN 1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons. Am J Hum Genet 57:8–21.

    PubMed  CAS  Google Scholar 

  25. Emanuel R, RA Ng, EC Moores, KE Jefferson, PA MacFaul, R Withers. 1977. Formes frustes of Marfan’s syndrome presenting with severe aortic regurgitation. Br Heart J 39:190–197.

    Article  PubMed  CAS  Google Scholar 

  26. Savunen T. 1987. Cardiovascular abnormalities in relatives of patients operated on forannuloaortic ectasia. Eur J Cardiothorac Surg 1:3–10.

    Article  PubMed  CAS  Google Scholar 

  27. Nicod P, C Bloor, M Godfrey, D Hollister, RE Pyeritz, H Dittrich, R Polikar, KL Peterson. 1989. Familial aortic dissecting aneurysm. J Am Coll Cardiol 13:811–819.

    Article  PubMed  CAS  Google Scholar 

  28. Francke U, MA Berg, K Tynan, T Brenn, W Liu, T Aoyama, C Gasner, DC Miller, H Furthmayr. 1995. A Gly1127Ser mutation in an EGF-like domain of the fibrillin-1 gene is a risk factor for ascending aortic aneurysm and dissection. Am J Hum Genet 56:1287–1296.

    PubMed  CAS  Google Scholar 

  29. Tsipouras P, R Del Mastro, M Sarfarazi, B Lee, E Vitale, AH Child, M Godfrey, RB Devereux, D Hewett, B Steinmann, D Viljoen, BC Sykes, M Kilpatrick, F Ramirez. 1992. Genetic linkage of the Marfan syndrome, ectopia lentis,and congenital contractural arachnodactyly to the fibrillin genes on chromosomes 15 and 5. N Engl J Med 326:905–909.

    Article  PubMed  CAS  Google Scholar 

  30. Edwards MJ, CJ Challinor, PW Colley, J Roberts, MW Partington, GE Hollway, HM Kozman, JC Mulley. 1994. Clinical and linkage study of a large family with simple ectopia lentis linked to FBN 1. Am J Med Genet 53:65–71.

    Article  PubMed  CAS  Google Scholar 

  31. Kainulainen K, L Karttunen, L Puhakka, L Sakai, L Peltonen. 1994. Mutations in the fibrillin gene responsible for dominant ectopia lentis and neonatal Marfan syndrome. Nature Genet 64–9.

    Google Scholar 

  32. Lönnqvist L, A Child, K Kainulainen, R Davidson, L Puhakka, L Peltonen. 1994. A novel mutation of the fibrillin gene causing ectopia lentis. Genomics 19:573–576.

    Article  PubMed  Google Scholar 

  33. Milewicz DM, J Grossfield, SN Cao, C Kielty, W Covitz, T Jewett. 1995. A mutation in FBN 1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome. J Clin Invest 95:2373–2378.

    Article  PubMed  CAS  Google Scholar 

  34. Shprintzen RJ, RB Goldberg. 1982. A recurrent pattern syndrome ofcraniosynostosis associated with arachnodactyly and abdominal hernias. JCraniofacial Genet Devel Biol 2:65–74.

    CAS  Google Scholar 

  35. Sood S, ZA Eldadah, WL Krause, I McIntosh, HC Dietz. 1996. Mutations in fibrillin-1 and the Marfanoid craniosynostosis (Shprintzen-Goldberg) syndrome. Nature Genet 12:209–211.

    Article  PubMed  CAS  Google Scholar 

  36. Devereux RB, WT Brown, R Kramer-Fox, I Sacks. 1982. Inheritance of mitral valve prolapse Effect of age and sex in gene expression. Ann InternMed 97:826–832.

    CAS  Google Scholar 

  37. Devereux RB, R Kramer-Fox, WT Brown, MK Shear, N Hartman, P Kligfield, EM Lutas, MC Spitzer, SD Litwin. 1986. Relation between clinical features of “mitral valve prolapse syndrome” and echocardiographically documented mitral valve prolapse. J AmColl Cardiol 8:763–772.

    Article  CAS  Google Scholar 

  38. Devereux RB, R Kramer-Fox, MK Shear, P Kligfield, R Pini, DD Savage. 1987. Diagnosis and classification of severity of mitral valve prolapse. Am Heart J 113:1265–1280.

    Article  PubMed  CAS  Google Scholar 

  39. Roman MJ, RB Devereux, R Kramer-Fox, MC Spitzer. 1989. Comparison of cardiovascular and skeletal features of primary mitral valve prolapse and Marfan syndrome. Am JCardio 63:317–21.

    Article  CAS  Google Scholar 

  40. Montgomery RA, MT Geraghty, E Bull, BD Gelb, M Johnson, I Mclntosh, CA Francomano, HC Dietz. 1998. Multiple molecular mechanisms underlying subdiagnostic variants of Marfan syndrome. Am J Hum Genet 63:1703–1711.

    Article  PubMed  CAS  Google Scholar 

  41. Glesby MJ, RE Pyeritz. 1989. Association of mitral valve prolapse and systemic abnormalities of connective tissue. JAMA 262:523–528

    Article  PubMed  CAS  Google Scholar 

  42. Stahl-Hallengren C, T Ukkonen, K Kainulainen, T Saxne, K Tornqvist, L Peltonen. 1994. An extra cysteine in 1 of the non-calcium-binding epidermal growth factor-like motifs of theFBNl polypeptide is connected to a novel variant of the Marfan syndrome. J Clin Invest 94:709–13.

    Article  PubMed  CAS  Google Scholar 

  43. Hecht F, RK Beals. 1972. “New” syndrome of congenital contractural arachnodactyly originally described by Marfan in 1896. Pediatrics 49:574–579.

    PubMed  CAS  Google Scholar 

  44. Viljoen D. 1994. Congenital contractural arachnodactyly. J Med Genet 31:640–643.

    Article  PubMed  CAS  Google Scholar 

  45. Putnam EA, H Zhang, F Ramirez, DM Milewicz. 1995. Fibrillin-2 (FBN2) mutations result in the Marfan-like disorder, congenital contractural arachnodactyly. Nature Genet 11:456–458.

    Article  PubMed  CAS  Google Scholar 

  46. Marfan MA. 1896. Un cas de deformation congenital des quatre membres plus prononcee aux extremities caracterisee. Bull Mem Soc Med Hop (Paris) 13:220–226.

    Google Scholar 

  47. Achard C. 1902. Arachnodactylie. Bull Mem Soc Med Hop (Paris) 19:834–840.

    Google Scholar 

  48. Börger F. 1914. Uber zwei Falle von Arachnodaktylie. Zschr Kinderheilk 12:161–184.

    Article  Google Scholar 

  49. Williams E. 1873-1879. Rare cases, with practical remarks. Trans AmOphthalmol Soc 2:291.

    Google Scholar 

  50. Weve H. 1931. Uber Arachnodaktylie (dystrophia mesodermalis congenita, Typus Marfan). Archiv Augenheilk 104:1–46.

    Google Scholar 

  51. Salle V. 1912. Uber einen Fall von angeborener Abnormalen grosse der Extremitaten mit einem an Akromegalie erinnernden Symptomenkomplex. Jahrb Kinderheilk 75:540–548.

    Google Scholar 

  52. Pyeritz RE, MA Wappel. 1983. Mitral valve dysfunction in the Marfan syndrome. Am J Med 74:797–807.

    Article  PubMed  CAS  Google Scholar 

  53. McKusick VA. 1955. The cardiovascular aspects of Marfan’s syndrome A heritable disorder of connective tissue. Circulation 11:321–341.

    Article  PubMed  CAS  Google Scholar 

  54. McKusick VA. 1956. Heritable disorders of connective tissue.Mosby, St. Louis. 68–71.

    Google Scholar 

  55. Ross R, P Bornstein. 1969. The elastic fiber. J CellBiol 40:366–381.

    Article  CAS  Google Scholar 

  56. Mecham RP, J Heuser. 1990. Three-dimensional organization of extracellular matrix in elastic cartilage as viewed by quick freeze, deep etch electron microscopy.ConnectTissue Res 24:83–93.

    Article  CAS  Google Scholar 

  57. Mecham RP, EC Davis. 1994. Elastic fiber structure and assembly. In Extracellular matrix assembly and structure. PD Yurchenco, DE Birk, and RP Mecham, eds. Academic Press, San Diego. 281–314.

    Google Scholar 

  58. Hollister DW, M Godfrey, LY Sakai, RE Pyeritz. 1990. Immunohistologic abnormalities of the microfibrillar-fiber system in the Marfan syndrome. N Engl J Med 323:152–159.

    Article  PubMed  CAS  Google Scholar 

  59. Kainulainen K, L Pulkkinen, A Savolainen, I Kaitila, L Peltonen. 1990. Location on chromosome 15 of the gene defect causing Marfan syndrome. N Engl J Med 323:935–939.

    Article  PubMed  CAS  Google Scholar 

  60. Dietz HC, RE Pyeritz, BD Hall, RG Cadle, A Hamosh, J Schwartz, DA Meyers, CA Francomano. 1991. The Marfan syndrome locus Confirmation of assignment to chromosome 15 and identification of tightly linked markers at 15ql5-q21.3. Genomics 9:355–361.

    Article  PubMed  CAS  Google Scholar 

  61. Magenis RE, CL Maslen, L Smith, L Allen, LY Sakai. 1991. Localization of the fibrillin (FBN) gene to chromosome 15,band q21.1. Genomics 11:346–351.

    Article  CAS  Google Scholar 

  62. Corson GM, SC Chalberg, HC Dietz, N Charbonneau, LY Sakai. 1993. Fibrillin binds calcium and is encoded by cDNAs that reveal amultidomain structure and alternatively splicedexons at the 5’ end. Genomics 17:468–475.

    Article  PubMed  Google Scholar 

  63. Pereira L, M D’Alessio, F Ramirez, JR. Lynch, B Sykes, T Pangilinan, J Bonadio. 1993. Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome. Hum Mol Genet 2:961–968.

    Article  PubMed  CAS  Google Scholar 

  64. Dietz H, U Francke, H Furthmayr, C Francomano, A De Paepe, R Devereux, F Ramirez, R Pyeritz. 1995. The question of heterogeneity in Marfan syndrome. Nature Genet 9:228–231.

    Article  PubMed  CAS  Google Scholar 

  65. Aoyama T, K Tynan, HC Dietz, U Francke, H Furthmayr. 1993. Missense mutations impair intracellular processing of fibrillin and microfibril assembly in Marfan syndrome. Hum Mol Genet 2:2135–2140.

    Article  PubMed  CAS  Google Scholar 

  66. Aoyama T, U Francke, HC Dietz, H Furthmayr. 1994. Quantitative differences in biosynthesis and extracellular deposition of fibrillin in cultured fibroblasts distinguish five groups of Marfan syndrome patients and suggest distinctpathogenetic mechanisms. J Clin Invest 94:130–137.

    Article  PubMed  CAS  Google Scholar 

  67. Dietz HC, RE Pyeritz. 1994. Molecular genetic approaches to investigating cardiovascular disease. Ann Rev Physiol 56:763–796.

    Article  CAS  Google Scholar 

  68. McKusick VA. 1999. On-line Mendelian inheritance in man. Johns Hopkins University, Baltimore http://www.onim@gdb.org

    Google Scholar 

  69. Geva T, SP Sanders, MS Diogenes, S Rockenmacher, R Van Praagh. 1990. Two-dimensional and Doppler echocardiographic and pathologic characteristics of the infantile Marfan syndrome. Am J Cardiol 65:1230–1237.

    Article  PubMed  CAS  Google Scholar 

  70. Milewicz DM, M Duvic. 1994. Severe neonatal Marfan syndrome resulting from a de novo 3-bp insertion into the fibrillin gene on chromosome 15. Am J Hum Genet 54:447–453.

    PubMed  CAS  Google Scholar 

  71. Wang M, C Price, J Han, J Cisler, K Imaizumi, MN Van Thienen, A De Paepe, M Godfrey. 1995. Recurrent mis-splicing of fibrillin exon 32 in two patients with neonatal Marfan syndrome. Hum Mol Genet 4:607–613.

    Article  PubMed  CAS  Google Scholar 

  72. Beighton P, A De Paepe, D Danks, G Finidori, R Goodman, JG Hall, DW Hollister, W Horton, VA McKusick, JM Opitz, FM Pope, RE Pyeritz, I Young. 1988. International nosology of heritable disorders of connective tissue, Berlin, 1986. Am J Med Genet 29:581–594.

    Article  PubMed  CAS  Google Scholar 

  73. Pereira L, O Levran, F Ramirez, JR Lynch, B Sykes, RE Pyeritz, HC Dietz. 1994. A molecular approach to the stratification of cardiovascular risk in families with Marfan syndrome. N Engl J Med 331:148–153.

    Article  PubMed  CAS  Google Scholar 

  74. De Paepe A, RB Devereux, HC Dietz, RCM Hennekam, RE Pyeritz. 1996. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 62:417–426.

    Article  PubMed  Google Scholar 

  75. Hall JG, UG Froster-Iskenius, JE Allanson. 1989. Handbook of normal physical measurements. Oxford University Press, Oxford. 270–275.

    Google Scholar 

  76. Mash AJ, JP Hegmann, BE Spivey. 1975. Genetic analysis of indices of corneal power and corneal astigmatism in human populations with varying incidences of strabismus. Invest Ophthalmol 14:826–832.

    PubMed  CAS  Google Scholar 

  77. Fledelius H. 1981. The growth of the eye. In Ultrasonography in ophthalmology. J. M. Thijssen and A. M. Verbeek AM, editors. W Junk, Dordrecht. 211.

    Chapter  Google Scholar 

  78. Godfrey M, N Vandemark, M Wang, M Velinov, D Wargowski, P Tsipouras, J Han, J Becker, W Robertson, S Droste, VH Rao. 1993. Prenatal diagnosis and a donor splice site mutation in fibrillin in a family with Marfan syndrome. Am J Hum Genet 53:472–480.

    PubMed  CAS  Google Scholar 

  79. Rantamäki T, L Lönnqvist, L Karttunen, A Child, L Peltonen. 1994. DNA diagnostics of the Marfan syndrome: Application of amplifiable polymorphic markers. Eur J Hum Genet 2:66–75.

    PubMed  Google Scholar 

  80. Eldadah ZA, JA Grifo, HC Dietz. 1995. Marfan syndrome as a paradigm for transcript-targeted preimplantation diagnosis of heterozygous mutations. Nature Med 1:798–803.

    Article  PubMed  CAS  Google Scholar 

  81. Lacro RV. 1996. Marfan syndrome. In Gellis and Kagan’s Current Pediatric Therapy 15. FD Burg, JR Ingelfinger, ER Wald, RA Polin, editors. W. B. Saunders Co., Philadelphia. 171–173.

    Google Scholar 

  82. Anonymous (American Academy of Pediatrics Committee on Genetics). 1996. Health supervision of children with Marfan syndrome. Pediatrics 98:978–982.

    Google Scholar 

  83. Roman MJ, RB Devereux, R Kramer-Fox, J O’Loughlin. 1989. Two-dimensional aortic root dimensions in normal children and adults. Am J Cardiol 64:507–512.

    Article  PubMed  CAS  Google Scholar 

  84. Roman MJ, SS Rosen, R Kramer-Fox, RB Devereux. 1993. The prognostic significance of the pattern of aortic root dilatation in the Marfan syndrome. J Am Coll Cardiol 22:1470–1476.

    Article  PubMed  CAS  Google Scholar 

  85. Sisk HE, KG Zahka, RE Pyeritz. 1983. The Marfan syndrome in early childhood Analysis of 15 patients diagnosed at less than 4 years of age. Am J Cardiol 52:353–358.

    Article  PubMed  CAS  Google Scholar 

  86. van Karnebeek CDM, K Gauvreau, SD Colan, RV Lacro. 1998. Clinical and echocardiographic predictors of adverse cardiovascular outcome in childhood Marfan syndrome (abstract). J Am Coll Card 31 No 2, Supp A:70A–71A.

    Article  Google Scholar 

  87. Gillinov AM, A Hulyalkar, DE Cameron, PW Cho, PS Greene, BA Reitz, VL Gott. 1994. Mitral valve operations in patients with the Marfan syndrome. J Thorac Cardiovasc Surg 107:724–731.

    PubMed  CAS  Google Scholar 

  88. Bowers D. 1961. The electrocardiogram in Marfan’s syndrome. Am J Cardiol 7:661–672.

    Article  Google Scholar 

  89. Bowers D. 1969. Primary abnormalities of the mitral valve in Marfan’s syndrome. Electrocardiographic findings. Br Heart J 31:676–678.

    Article  PubMed  CAS  Google Scholar 

  90. Banerjee AK. 1988. Marfan’s syndrome associated with Wolff-Parkinson-White syndrome type B. Jpn Heart J 29:377–380.

    Article  PubMed  CAS  Google Scholar 

  91. Kligfield P, P Levy, RB Devereux, DD Savage. 1987. Arrhythmias and sudden death in mitral valve prolapse. Am J Cardiol 113:1298–1307.

    CAS  Google Scholar 

  92. Chen S, LF Fagan, S Nouri, JL Donahoe. 1985. Ventricular dysrhythmias in children with Marfan’s syndrome. Am J Dis Child 139:273–276.

    PubMed  CAS  Google Scholar 

  93. Mehta D, S Wafa, A Child, AJ Camm. 1989. Arrhythmia in Marfan syndrome. Am J Med Genet 32:247.

    Google Scholar 

  94. Savolainen A, M Kupari, L Toivonen, I Kaitila, M Viitasalo. 1997. Abnormal ambulatory electrocardiographic findings in patients with Marfan syndrome. J Int Med 241:221–226.

    Article  CAS  Google Scholar 

  95. Halpern BL, F Char, JL Murdoch, WB Horton, VA McKusick. 1971. A prospectus on the prevention of aortic rupture in the Marfan syndrome with data on survivorship without treatment. Johns Hopkins Med Journal 129:123–129.

    CAS  Google Scholar 

  96. Simpson CF. 1972. Sotalol for the protection of turkeys from the development of beta-aminopropionitrile-induced aortic ruptures. Br J Pharmacol 45:385–390.

    Article  PubMed  CAS  Google Scholar 

  97. Simpson CF, JM Kling, RF Palmer. 1970. Beta-aminopropionotrile-induced dissecting aneurysms in turkeys: Treatment with propranolol.Toxicol Appl Pharmacol 16:143–153.

    Article  PubMed  CAS  Google Scholar 

  98. Salim MA, BS Alpert, JC Ward, RE Pyeritz. 1994. Effect of beta-adrenergic blockade on aortic root rate of dilation in the Marfan syndrome. Am J Cardiol 74:629–633.

    Article  PubMed  CAS  Google Scholar 

  99. Opie LH, EH Sonnenblick, NM Kaplan, U Thadani. 1987. Beta-blocking agents. In Drugs for the heart, 2nd ed. LH Opie, K Chatterjee, BJ Gersh., editors. Grune & Stratton, Orlando. 1–16.

    Google Scholar 

  100. Phelps SJ, BS Alpert, JL Ward, JA Pieper, JJ Lima. 1995. Absorption pharmacokinetics of atenolol in patients with the Marfan syndrome. J Clin Pharmacol 35:268–274.

    PubMed  CAS  Google Scholar 

  101. Gott VL, RE Pyeritz, GJ Magovern, DE Cameron, VA McKusick. 1986. Surgical treatment of aneurysms of the ascending aorta in the Marfan syndrome. N Engl J Med 314:1070–1074.

    Article  PubMed  CAS  Google Scholar 

  102. Gott VL, PS Greene, DE Alejo, DE Cameron, DC Naftel, DC Miller, AM Gillinov, JC Laschinger, RE Pyeritz. 1999. Replacement of the aortic root in patients with Marfan’s syndrome. N Engl J Med 340:1307–1313.

    Article  PubMed  CAS  Google Scholar 

  103. Bentall H, A De Bono. 1968. A technique for complete replacement of the ascending aorta. Thorax 23:338–339.

    Article  PubMed  CAS  Google Scholar 

  104. David TE, CM Feindel. 1992. An aortic valve-sparing operation for patients with aortic incompetence and aneurysm of the ascending aorta. J Thorac Cardiovasc Surg 103:617–622.

    PubMed  CAS  Google Scholar 

  105. Yacoub MH, P Gehle, EJ Birks, A Child, R Radley-Smith. 1998. Late results of a valve-preserving operation in patients with aneurysms in the ascending aorta and root. J Thorac Cardiovasc Surg 115:1080–1090.

    Article  PubMed  CAS  Google Scholar 

  106. Tsang VT, A Pawade, TR Karl, RB Mee. 1994. Surgical management of Marfan syndrome in children. J Card Surg 9:50–54.

    Article  PubMed  CAS  Google Scholar 

  107. Gillinov AM, KJ Zehr, JM Redmond, VL Gott, HC Dietz, BA Reitz, DE Cameron. 1997. Cardiac operations in children with Marfan’s syndrome. Ann Thorac Surg 64:1140–1145.

    Article  PubMed  CAS  Google Scholar 

  108. Pyeritz RE. 1981. Maternal and fetal complications of pregnancy in the Marfan syndrome. Am J Med 71:784–790.

    Article  PubMed  CAS  Google Scholar 

  109. Rossiter JP, JT Repke, AJ Morales, EA Murphy, RE Pyeritz. 1995. A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am J Obstet Gynecol 173:1599–1606.

    Article  PubMed  CAS  Google Scholar 

  110. Maumenee IH. 1981. The eye in the Marfan syndrome. Trans Am Ophthalmol 79:684–733.

    CAS  Google Scholar 

  111. Sponseller PD, W Hobbs, LH Riley III, RE Pyeritz. 1995. The thoracolumbar spine in Marfan syndrome. J Bone JointSurg 77-A; 867–876.

    Google Scholar 

  112. Steinberg I. 1966. A simple screening test for the Marfan syndrome. Am J Roentgen 197:118.

    Google Scholar 

  113. Walker, B. A. and J. L. Murdoch. 1970. The wrist sign A useful physical finding in the Marfan syndrome. Arch Intern Med 71:349.

    Google Scholar 

  114. Kuhlman JE, WW Scott Jr, EK Fishman, RE Pyeritz SS Siegleman. 1987. Protrusio acetabuli in Marfan syndrome. Radiology 164:415–417.

    PubMed  CAS  Google Scholar 

  115. Arn PH, LR Scherer, JA Haller Jr, RE Pyeritz. 1989. Clinical outcomes of pectus excavatum in the Marfan syndrome and in the general population. J Pediatr 115:954–958.

    Article  PubMed  CAS  Google Scholar 

  116. Pyeritz RE, EK Fishman, BA Bernhardt, SS Siegelman. 1988. Durai ectasia is a common feature of the Marfan syndrome. Am J Hum Genet 43:726–732.

    PubMed  CAS  Google Scholar 

  117. Stern WE. 1988. Durai ectasia and the Marfan syndrome. J Neurosurg 69:221–227.

    Article  PubMed  CAS  Google Scholar 

  118. Hofman KJ, BA Bernhardt, RE Pyeritz. 1988. Marfan syndrome Neuropsychologic aspects. Am J Med Genet 31:331–338.

    Article  PubMed  CAS  Google Scholar 

  119. Hall J, RE Pyeritz, DL Dudgeon, JA Haller Jr. 1984. Pneumothorax in the Marfan syndrome Prevalence and therapy. AnnThorac Surg 37:500–504

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Children’ s Hospital, Boston, USA

    Ronald V. Lacro M.D.

  2. Department of Pediatrics, Harvard Medical School, Boston, MA, 02115, USA

    Ronald V. Lacro M.D.

Authors
  1. Ronald V. Lacro M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Cardiology, Children’s Hospital, Boston, USA

    Charles I. Berul M.D.

  2. Department of Pediatrics, Harvard Medical School, Boston, 02115, MA, USA

    Charles I. Berul M.D.

  3. Departments of Pediatrics (Cardiology), Molecular and Human Genetics, Texas Children’s Hospital, Baylor College of Medicine, Houston, 77030, TX, USA

    Jeffrey A. Towbin M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media New York

About this chapter

Cite this chapter

Lacro, R.V. (2000). Marfan Syndrome and Related Disorders of Fibrillin. In: Berul, C.I., Towbin, J.A. (eds) Molecular Genetics of Cardiac Electrophysiology. Developments in Cardiovascular Medicine, vol 231. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4517-0_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-4517-0_21

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7037-6

  • Online ISBN: 978-1-4615-4517-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation